Inhaled Corticosteroid/Long-Acting β₂-Agonist Combination Therapy for Asthma: Attitudes of Specialists in Europe

By  

International Archives of Allergy and Immunology, Vol. 157, Iss. 3, 2011-11 ,pp. : 303-310

Karger

Access to resources Recommend Favorite

Addition of a 5-lipoxygenase-activating protein inhibitor to an inhaled corticosteroid (ICS) or an ICS/long-acting beta-2-agonist combination in subjects with asthma

By Snowise Neil G.   Clements Diane   Ho Shu-Yen   Follows Richard M.A.  

Current Medical Research and Opinion, Vol. 29, Iss. 12, 2013-12 ,pp. : 1663-1674

Informa Healthcare

Access to resources Recommend Favorite

Long‐acting muscarinic antagonist + long‐acting beta agonist versus long‐acting beta agonist + inhaled corticosteroid for COPD: A systematic review and meta‐analysis

By  

RESPIROLOGY (ELECTRONIC), Vol. 20, Iss. 8, 2015-11 ,pp. : 1153-1159

John Wiley & Sons Inc

Access to resources Recommend Favorite

Comparison of an Inhaled Corticosteroid (Triamcinolone Acetonide) to a Long–Acting Bronchodilator (Salmeterol), the Combination, and Placebo in Mild–Moderate Adult Asthmatic Patients

By  

International Archives of Allergy and Immunology, Vol. 118, Iss. 2-4, 1999-04 ,pp. : 345-346

Karger

Access to resources Recommend Favorite

Improving asthma control in patients suboptimally controlled on inhaled steroids and long-acting β2-agonists: addition of montelukast in an open-label pilot study

By Dupont Lieven   Potvin Emmanuel   Korn Dana   Lachman Albert   Dramaix Michèle   Gusman Julie   Peché Rudi  

Current Medical Research and Opinion, Vol. 21, Iss. 6, 2005-06 ,pp. : 863-870

Informa Healthcare

Access to resources Recommend Favorite